• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans

tetano

Editor, Senior Moderator
Sci Immunol. 2017 Jul 14;2(13). pii: eaan2676. doi: 10.1126/sciimmunol.aan2676.
[h=1]Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.[/h] Andrews SF[SUP]1[/SUP], Joyce MG[SUP]2[/SUP], Chambers MJ[SUP]2[/SUP], Gillespie RA[SUP]2[/SUP], Kanekiyo M[SUP]2[/SUP], Leung K[SUP]2[/SUP], Yang ES[SUP]2[/SUP], Tsybovsky Y[SUP]3[/SUP], Wheatley AK[SUP]4[/SUP], Crank MC[SUP]2[/SUP], Boyington JC[SUP]2[/SUP], Prabhakaran MS[SUP]2[/SUP], Narpala SR[SUP]2[/SUP], Chen X[SUP]2[/SUP], Bailer RT[SUP]2[/SUP], Chen G[SUP]2[/SUP], Coates E[SUP]2[/SUP], Kwong PD[SUP]2[/SUP], Koup RA[SUP]2[/SUP], Mascola JR[SUP]2[/SUP], Graham BS[SUP]2[/SUP], Ledgerwood JE[SUP]2[/SUP], McDermott AB[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Antigenic drift and shift of influenza strains underscore the need for broadly protective influenza vaccines. One strategy is to design immunogens that elicit B cell responses against conserved epitopes on the hemagglutinin (HA) stem. To better understand the elicitation of HA stem-targeted B cells to group 1 and group 2 influenza subtypes, we compared the memory B cell response to group 2 H7N9 and group 1 H5N1 vaccines in humans. Upon H7N9 vaccination, almost half of the HA stem-specific response recognized the group 1 and group 2 subtypes, whereas the response to H5N1 was largely group 1-specific. Immunoglobulin repertoire analysis of HA-specific B cells indicated that the H7N9 and H5N1 vaccines induced genetically similar cross-group HA stem-binding B cells, albeit at a much higher frequency upon H7N9 vaccination. These data suggest that a group 2-based stem immunogen could prove more effective than a group 1 immunogen at eliciting broad cross-group protection in humans.
Copyright ? 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.


PMID: 28783708 DOI: 10.1126/sciimmunol.aan2676
 
Back
Top Bottom